Loading...
•
Dec 31, 2025
•/
Materialise Q4 2025 Earnings Report
Materialise reported higher revenue and net profit for the fourth quarter of 2025, driven by strong growth in its Medical segment and improved profitability.
Key Takeaways
In Q4 2025, Materialise increased revenue by 6.8% year-over-year to €70.2 million, with strong performance in the Medical segment. Gross margin improved to 58.1% and operating profit turned positive, leading to net profit of €6.2 million.
Revenue grew 6.8% year-over-year, led by 16.3% growth in the Medical segment.
Gross margin improved to 58.1%, reflecting operational efficiency gains.
Operating profit was €3.1 million, compared to a loss in the prior-year period.
Net profit more than doubled year-over-year to €6.2 million.
Revenue by Segment
Forward Guidance
For fiscal year 2026, Materialise expects revenue growth and improved Adjusted EBIT, supported by continued strength in Medical and Software, while Manufacturing faces macroeconomic headwinds.
Positive Outlook
- Full year 2026 revenue expected between 273000000 and 283000000 EUR.
- Adjusted EBIT expected between 10000000 and 12000000 EUR.
- Continued strong revenue growth anticipated in the Medical segment.
- Ongoing transition to cloud-based subscription model in Software.
- Disciplined cost control and optimization initiatives.
Challenges Ahead
- Macroeconomic headwinds expected to persist in industrial markets.
- Manufacturing segment continues transition impacting near-term performance.
- Unfavorable foreign exchange effects could impact results.
- Ongoing investments may pressure short-term margins.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...